|
Volumn 8, Issue 2, 2006, Pages 114-119
|
Drug-induced metabolic syndrome.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
IMMUNOSUPPRESSIVE AGENT;
NEUROLEPTIC AGENT;
ORAL CONTRACEPTIVE AGENT;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
DISORDERS OF CARBOHYDRATE METABOLISM;
DRUG EFFECT;
HUMAN;
HYPERGLYCEMIA;
HYPERLIPIDEMIA;
LIPID METABOLISM;
METABOLIC SYNDROME X;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
REVIEW;
RISK FACTOR;
WEIGHT GAIN;
ANTIHYPERTENSIVE AGENTS;
ANTIPSYCHOTIC AGENTS;
CARDIOVASCULAR DISEASES;
CONTRACEPTIVES, ORAL;
DIABETES MELLITUS, TYPE 2;
GLUCOSE METABOLISM DISORDERS;
HUMANS;
HYPERGLYCEMIA;
HYPERLIPIDEMIAS;
IMMUNOSUPPRESSIVE AGENTS;
LIPID METABOLISM;
METABOLIC SYNDROME X;
OBESITY;
RISK FACTORS;
WEIGHT GAIN;
|
EID: 34547767113
PISSN: 15246175
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1524-6175.2006.04751.x Document Type: Review |
Times cited : (36)
|
References (39)
|